about
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote ca...
Read More
8.89
0.28
(3.25%)
1.2M
XNAS Volume
XNAS 26 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Verastem Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..